Jim Simons Novan, Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.41 - $1.4 $3,577 - $12,216	8,726 Added 10.22%	94,100 $40,000
Q1 2023 May 12, 2023	SELL	$1.05 - $2.04 $74,865 - $145,452	-71,300 Reduced 45.51%	85,374 $111,000
Q4 2022 Feb 13, 2023	SELL	$0.82 - $1.48 $96,987 - $175,051	-118,278 Reduced 43.02%	156,674 $229,000
Q3 2022 Nov 14, 2022	SELL	$1.76 - $3.03 $65,334 - $112,479	-37,122 Reduced 11.9%	274,952 $514,000
Q2 2022 Aug 12, 2022	SELL	$2.29 - $3.86 $161,653 - $272,481	-70,591 Reduced 18.45%	312,074 $727,000

Q1 2022 May 13, 2022	BUY	$2.95 - $4.41 $112,964 - $168,872	38,293 Added 11.12%	382,665 $1.51 Million
Q4 2021 Feb 11, 2022	BUY	$4.03 - $8.15 $1.39 Million - $2.81 Million	344,372 New	344,372 $1.44 Million

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.